当前位置: 首页 >> 检索结果
421. A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain.
作者: R Ainsworth.;K Dziedzic.;L Hiller.;J Daniels.;A Bruton.;J Broadfield.
来源: Rheumatology (Oxford). 2007年46卷5期815-20页
To compare the effectiveness of manual therapy and ultrasound (US) with manual therapy and placebo ultrasound (placebo US) in the treatment of new episodes of unilateral shoulder pain referred for physiotherapy.
422. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years.
作者: V Strand.;A Balbir-Gurman.;K Pavelka.;P Emery.;N Li.;M Yin.;P B Lehane.;S Agarwal.
来源: Rheumatology (Oxford). 2006年45卷12期1505-13页
To evaluate the long-term impact on physical function of a single course of rituximab in rheumatoid factor, seropositive patients with active rheumatoid arthritis (RA) despite ongoing methotrexate treatment.
423. Randomized trial of two physiotherapy interventions for primary care neck and back pain patients: 'McKenzie' vs brief physiotherapy pain management.
作者: J Klaber Moffett.;D A Jackson.;E D Gardiner.;D J Torgerson.;S Coulton.;S Eaton.;M P Mooney.;C Pickering.;A J Green.;L G Walker.;S May.;S Young.
来源: Rheumatology (Oxford). 2006年45卷12期1514-21页
Interventions that take psychosocial factors into account are recommended for patients with persistent back or neck pain. We compared the effectiveness of a brief physiotherapy pain management approach using cognitive-behavioural principles (Solution-Finding Approach-SFA) with a commonly used method of physical therapy (McKenzie Approach-McK).
424. Engagement and satisfaction with an Internet-based physical activity intervention in patients with rheumatoid arthritis.
作者: M H van den Berg.;H K Ronday.;A J Peeters.;E M Voogt-van der Harst.;M Munneke.;F C Breedveld.;T P M Vliet Vlieland.
来源: Rheumatology (Oxford). 2007年46卷3期545-52页
To assess the engagement in and satisfaction with an Internet-mediated physical activity intervention with individual supervision in patients with rheumatoid arthritis (RA).
425. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
作者: C O Bingham.;A I Sebba.;B R Rubin.;G E Ruoff.;J Kremer.;S Bird.;S S Smugar.;B J Fitzgerald.;K O'Brien.;A M Tershakovec.
来源: Rheumatology (Oxford). 2007年46卷3期496-507页
To compare the efficacy of etoricoxib 30 mg with the generally maximum recommended dose of celecoxib, 200 mg, in the treatment of osteoarthritis (OA) in two identically designed studies.
440. A clinical trial of specialist footwear for patients with rheumatoid arthritis.
The structural and functional changes in the RA foot often affect the patient's gait and mobility, impacting on the patient's quality of life. Successful management of these foot pathologies and resultant problems can involve the provision of specialist therapeutic footwear. The aim of the study was to evaluate the value of a new footwear design based on patients' opinions compared with a traditional footwear design.
|